Recent Mergers and Acquisitions

Pfizer acquisition of Medivation, Inc.

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Medivation, Inc. (Nasdaq: MDVN), a biopharmaceutical company, for $14 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

Topics

Pfizer acquisition of Medivation, Inc.

Topics

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Medivation, Inc. (Nasdaq: MDVN), a biopharmaceutical company, for $14 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.